NCT00209027View on ClinicalTrials.gov

The Effects of Aripiprazole on the Processing of Rewards in Schizophrenia

NATerminatedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

December 31, 2010

Study Completion Date

April 30, 2011

Conditions

Schizophrenia

Interventions

OTHER

fMRI

fMRI scanning during behavioral reward task

DRUG

Aripiprazole

30 mg by mouth once daily

Trial Locations (1)

30033

Atlanta VA Medical Center, Decatur

Sponsors

Collaborators (1)

Bristol-Myers Squibb

All Listed Sponsors

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Emory University

OTHER

NCT00209027 - The Effects of Aripiprazole on the Processing of Rewards in Schizophrenia | Biotech Hunter | Biotech Hunter